Potentiation of chemotherapy by low-level ultrasound


     Related Videos

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: (1016)   Date: (27-01-09)   Pages: ()
    • Author:  Harrison GH  Balcer-Kubiczek EK  Eddy HA.  

    • Abstract:  Potentiation of chemotherapy by low-level ultrasound. Harriso n GH, Balcer-Kubiczek EK, Eddy HA. Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore 21201. We have performed in vitro and in vivo tests to determine whether ultrasound (US) at levels lower than previously investigated by others could still potentiate chemotherapeutic cell killing. Positive results were obtained with adriamycin and diaziquone. Two types of low-level US were effective: tone-burst US (10% duty cycle, 1.765 MHz, ISATA = 0.25 W/cm2), and pulsed US (2.5 MHz centre frequency, 1 kHz repetition frequency, MPa-level pressure amplitudes), distributed uniformly over the biological target. These US beams were non-cytotoxic and produced negligible temperature elevation. Statistically significant US-induced increases in drug cytotoxicity were observed in CHO and MCF-7 WT but not V79 cells for 1-h drug exposures at several drug concentrations. The effects of combined drug and US treatments in vivo were studied by measuring post-treatment volume changes in uterine cervical squamous cell carcinoma implanted in the cheek pouch of the Syrian hamster. A statistically significant US-drug synergy in tumour volume reduction was observed with adriamycin and diaziquone. PMID: 1677389 [PubMed - indexed for MEDLINE]

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • New target for Alzheimer's drugs
              UC Riverside biomedical scientists have identified a new link between a protein (beta-arrestin) and short-term memory that could open new doors for the therapeutic treatment of neurological disorders, particularly Alzheimer's disease. They show that if beta-arrestin is removed from neurons, short-term memory loss is prevented. But beta-arrestin is also required for normal learning/memory. The ...
            • Raise Your Hand to Support People with Rare Diseases
              Today, Lundbeck announced its third annual Raise Your Hand to Fight Rare Diseases campaign in support of Rare Disease Day, a worldwide observance on February 29 to increase awareness of rare diseases.
            • New link between beta-arrestin and short-term memory
              Biomedical scientists at the University of California, Riverside have identified a new link between a protein called beta-arrestin and short-term memory that could open new doors for the therapeutic treatment of neurological disorders, particularly Alzheimer's disease.
            • In Flies, a Prion-Like Protein Helps Maintain Long-Term Memories | 80beats
              What’s the News: When prions or amyloids make the news, it’s usually because they cause mad cow disease or Alzheimer’s — prions , after all, cause any proteins they touch to become as misfolded as they are, and amyloids , which are large clumps of wadded-together proteins, can jam the workings of cells. But a new study in Cell suggests that a prion-like protein that forms amyloids has a normal ...
            • Press Release
              Today, Lundbeck announced its third annual Raise Your Hand to Fight Rare Diseases campaign in support of Rare Disease Day, a worldwide observance on February 29 to increase awareness of rare diseases.
            • New paintings and performative photographs by Dorte Jelstrup at Galeri Lars Olsen
              Dorte Jelstrup, Untitled (But I can dream about you), 2011. Ink jet print on HahnemĂĽhle paper. Ed. of 5. COPENHAGEN.-

                 Related on Wikipedia




























             

            Powered free by PHPmotion